Walleye Trading LLC Mirati Therapeutics, Inc. Put Options Transaction History

Walleye Trading LLC

16 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$41.99 - $62.38 $188,955 - $280,710	4,500 Added 281.25%	6,100 $358,000
Q3 2023 Nov 14, 2023	SELL	$27.8 - $45.35 $61,160 - $99,770	-2,200 Reduced 57.89%	1,600 $69,000
Q2 2023 Aug 14, 2023	SELL	$36.13 - $49.49 $28,904 - $39,592	-800 Reduced 17.39%	3,800 $137,000
Q1 2023 May 15, 2023	BUY	$36.54 - $54.26 $168,084 - $249,596	4,600 New	4,600 $171,000
Q3 2022 Nov 14, 2022	BUY	$59.5 - $86.7 $1.03 Million - $1.5 Million	17,300 Added 865.0%	19,300 $1.35 Million
Q2 2022 Aug 08, 2022	BUY	$39.16 - $88.71 $27,411 - $62,096	700 Added 53.85%	2,000 $134,000
Q1 2022 May 16, 2022	SELL	$75.82 - $150.97 $113,729 - $226,455	-1,500 Reduced 53.57%	1,300 $107,000
Q4 2021 Feb 14, 2022	BUY	$132.01 - $190.29 $92,407 - $133,203	700 Added 33.33%	2,800 $411,000
Q3 2021 Nov 15, 2021	BUY	$132.13 - $177.45 $277,473 - $372,645	2,100 New	2,100 $372,000
Q1 2021 May 17, 2021	SELL	$158.92 - $221.61 $31,783 - $44,322	-200 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$162.05 - $240.27 $1.36 Million - $2.02 Million	-8,400 Reduced 97.67%	200 $44,000
Q4 2019 Feb 14, 2020	BUY	$70.76 - $128.86 $21,228 - $38,658	300 Added 3.61%	8,600 $1.11 Million
Q3 2019 Nov 14, 2019	SELL	$77.91 - $109.6 $70,119 - $98,640	-900 Reduced 9.78%	8,300 $647,000
Q2 2019 Aug 14, 2019	BUY	$59.49 - $104.71 $226,062 - $397,898	3,800 Added 70.37%	9,200 $948,000
Q1 2019 May 15, 2019	SELL	$43.65 - $78.95 $148,410 - $268,430	-3,400 Reduced 38.64%	5,400 $396,000
Q4 2018 Feb 14, 2019	BUY	$32.0 - $47.43 $281,600 - $417,384	8,800 New	8,800 $373,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.